Last checked
September 30, 2026
Supplier reviews
Public-record reviewReferral link inactive
Supplier documentation profile
Avelqor Labs
Avelqor Labs is a Swiss-dispatched research-material storefront that also maintains a separately presented sports-nutrition catalogue. Its public trust center distinguishes independent laboratory reports, supplier documentation, pending batch linkage, and testing that has not yet been completed. Public records describe a Freedom Diagnostics Retatrutide report covering LC-MS identity, HPLC-UV purity, net content, endotoxin, and microbial PCR, plus supplier documentation for GHK-Cu and Retatrutide. Avelqor expressly states that none of these records proves applicability to current inventory until the physical lot is matched, and that its first Avelqor-linked independent test remains pending. The site also discloses that the business remains pre-incorporation following approval of the founder's Estonian e-Residency application.
Documented
9
Supplier-reported
0
Unresolved
2
Contradicted
0
Relationship
No active referral relationship
Editorial boundary
Qualified laboratory and in-vitro research context only
Quick assessment
Is Avelqor Labs worth a closer look?
Start with the supplier site if the catalog fit looks useful, then check the tracked listings and evidence ledger before relying on any specific product claim.
No active referral link is used for this supplier profile.
Tracked listings
0
In-stock records
0
Products with 2+ documented fields
0
Discount code
None documented
What we could document
9
Review fields connected to directly inspectable public records. Each finding and source basis appears below.
What remains unresolved
2
Fields not directly established by the reviewed records. This does not prove that testing or documentation does not exist.
Tracked catalog
Exact products matched by PDD
0 tracked listings
No exact-strength price records are published for this supplier yet. This does not affect its documentation review.
Procurement details
Business policies not yet documented
PDD has not yet preserved dated, directly reviewable records for this supplier's ship-from location, regions served, processing time, free-shipping threshold, payment methods, or refund and replacement policy. We do not infer those details from a storefront location or checkout availability.
This section will expand into field-level records as eligible supplier policies are documented.
Evidence ledger
What the reviewed records support
Evidence and COA records last reviewed September 30, 2026. Missing documentation remains visible and is not converted into a negative claim.
| Review field | State | Finding and limitation | Basis |
|---|---|---|---|
| Public COA access | Documented | A public documentation hub identifies the material, report source, report or accession reference, reported lot, dates, analytical scope, results, external verification route where available, and present linkage status. | COA and batch-verification hub + trust center |
| Lot traceability | Unresolved | The reviewed reports include lot or task references, but Avelqor labels their relationship to current inventory as pending. Its first Avelqor sample-specific independent test has been requested but is not complete. | COA hub + trust center + testing pipeline |
| Laboratory provenance | Documented | The records identify Freedom Diagnostics Testing and VeriChem Global Labs and disclose the named clients or applicants. A separate supplier report is explicitly described as non-accredited and without legal certification validity. | COA and batch-verification hub |
| Chromatographic purity | Documented | A Freedom Diagnostics record reports HPLC-UV purity of 99.80% for Retatrutide, while a VeriChem supplier record reports HPLC purity of 99.674% for GHK-Cu. Neither is represented as proof of the current Avelqor lot. | COA and batch-verification hub |
| Molecular identity | Documented | The Freedom Diagnostics Retatrutide record reports identity confirmation by LC-MS with a public lookup code; Avelqor labels its inventory linkage as pending. | COA hub + Freedom Diagnostics verification reference |
| Measured quantity | Documented | The Freedom Diagnostics record reports 11.31 mg net content for a Retatrutide sample, and a separate supplier analytical report states 10.11 mg per vial. Current Avelqor-lot linkage remains unresolved. | COA and batch-verification hub |
| Sterility testing | Documented | The Freedom Diagnostics record reports no detectable microbial DNA by microbial PCR. This is a documented result for that sample, not confirmation of sterility or current Avelqor inventory. | COA and batch-verification hub |
| Endotoxin testing | Documented | The Freedom Diagnostics record reports a pass at the assay sensitivity threshold of 0.05 EU/mL or less. Avelqor does not transfer this result to unmatched inventory lots. | COA and batch-verification hub |
| Research-use positioning | Documented | The site-entry confirmation and research-use policy restrict research materials to lawful laboratory and analytical research and exclude human or veterinary use, consumption, and administration. Consumer supplements are presented separately. | Homepage entry gate + research-use compliance + catalogue separation |
| Marketing consistency | Unresolved | The reviewed research pages use careful evidence qualifiers and separate sports-nutrition products, but PDD has not completed a page-level review of every product, research article, or commercial destination. | Homepage + catalogue + trust center + sampled documentation pages |
| Business identity | Documented | The trust center states that the founder's Estonian e-Residency application is approved but Avelqor Labs remains pre-incorporation. PDD therefore does not present it as a completed Swiss or Estonian legal entity. | Trust center + company-status disclosure |
Public COA access
DocumentedA public documentation hub identifies the material, report source, report or accession reference, reported lot, dates, analytical scope, results, external verification route where available, and present linkage status.
Basis: COA and batch-verification hub + trust center
Lot traceability
UnresolvedThe reviewed reports include lot or task references, but Avelqor labels their relationship to current inventory as pending. Its first Avelqor sample-specific independent test has been requested but is not complete.
Basis: COA hub + trust center + testing pipeline
Laboratory provenance
DocumentedThe records identify Freedom Diagnostics Testing and VeriChem Global Labs and disclose the named clients or applicants. A separate supplier report is explicitly described as non-accredited and without legal certification validity.
Basis: COA and batch-verification hub
Chromatographic purity
DocumentedA Freedom Diagnostics record reports HPLC-UV purity of 99.80% for Retatrutide, while a VeriChem supplier record reports HPLC purity of 99.674% for GHK-Cu. Neither is represented as proof of the current Avelqor lot.
Basis: COA and batch-verification hub
Molecular identity
DocumentedThe Freedom Diagnostics Retatrutide record reports identity confirmation by LC-MS with a public lookup code; Avelqor labels its inventory linkage as pending.
Basis: COA hub + Freedom Diagnostics verification reference
Measured quantity
DocumentedThe Freedom Diagnostics record reports 11.31 mg net content for a Retatrutide sample, and a separate supplier analytical report states 10.11 mg per vial. Current Avelqor-lot linkage remains unresolved.
Basis: COA and batch-verification hub
Sterility testing
DocumentedThe Freedom Diagnostics record reports no detectable microbial DNA by microbial PCR. This is a documented result for that sample, not confirmation of sterility or current Avelqor inventory.
Basis: COA and batch-verification hub
Endotoxin testing
DocumentedThe Freedom Diagnostics record reports a pass at the assay sensitivity threshold of 0.05 EU/mL or less. Avelqor does not transfer this result to unmatched inventory lots.
Basis: COA and batch-verification hub
Research-use positioning
DocumentedThe site-entry confirmation and research-use policy restrict research materials to lawful laboratory and analytical research and exclude human or veterinary use, consumption, and administration. Consumer supplements are presented separately.
Basis: Homepage entry gate + research-use compliance + catalogue separation
Marketing consistency
UnresolvedThe reviewed research pages use careful evidence qualifiers and separate sports-nutrition products, but PDD has not completed a page-level review of every product, research article, or commercial destination.
Basis: Homepage + catalogue + trust center + sampled documentation pages
Business identity
DocumentedThe trust center states that the founder's Estonian e-Residency application is approved but Avelqor Labs remains pre-incorporation. PDD therefore does not present it as a completed Swiss or Estonian legal entity.
Basis: Trust center + company-status disclosure
Evidence definitions
Documented
Connected to a directly reviewable public record.
Supplier-reported
Stated by the supplier but not independently confirmed.
Unresolved
The records reviewed do not support a conclusion either way.
Contradicted
Available records or statements materially disagree.
Open verification work
- Recheck the first Avelqor-linked Retatrutide test when the laboratory report is completed and published.
- Confirm the physical inventory lot and chain-of-custody record before treating any supplier or third-party report as applicable to current stock.
- Verify each laboratory, report identifier, public lookup result, method, and acceptance criterion independently.
- Track legal-entity formation and replace the pre-incorporation disclosure only after an official registry record is available.
- Audit additional catalog lots and keep identity, purity, quantity, endotoxin, microbial, sterility, and elemental-impurity findings separate.
Public records reviewed
Sources accessed and assessed September 30, 2026. These are research-source links, not commercial referrals.
Limit of review
This profile is not proof of safety, efficacy, sterility, authenticity, regulatory status, or suitability. A result supports only the attribute actually measured.
Affiliate disclosure
Potential compensation does not change evidence states, publication thresholds, placement, or conclusions. No referral link is active during review.